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Summary
Fosfomycin is a clinically utilized, highly effective
antibiotic, which is active against methicillin- and
vancomycin-resistant pathogens. Here we report the
cloning and characterization of a complete fosfomycin
biosynthetic cluster from Streptomyces fradiae and
heterologous production of fosfomycin in S. lividans.
Sequence analysis coupled with gene deletion and
disruption revealed that the minimal cluster consists
of fom1-4, fomA-D. A LuxR-type activator that was
apparently required for heterologous fosfomycin
production was also discovered w13 kb away from
the cluster and was named fomR. The genes fomE
and fomF, previously thought to be involved in fosfo-
mycin biosynthesis, were shown not to be essential
by gene disruption. This work provides new insights
into fosfomycin biosynthesis and opens the door for
fosfomycin overproduction and creation of new ana-
logs via biomolecular pathway engineering.
Introduction
Microbial resistance to antibiotics is rapidly increasing,
posing a real threat to human health and demanding
treatments that are effective against resistant patho-
gens. Fosfomycin is a low molecular weight natural
product produced by several species of Pseudomonas
[1] and Streptomyces [2] that exhibits broad spectrum
antimicrobial activity against gram-negative and gram-
positive bacteria [3]. Fosfomycin was first identified
nearly 40 years ago [2] and is an FDA approved drug
that has become the first choice for treatment of certain
types of infections [4–8]. Attractively, fosfomycin has
been proven effective for the treatment of cephalospo-
rin- and penicillin-resistant Streptococcus pneumoniae
[9, 10] and is effective against methicillin-resistant [11]
and vancomycin-resistant [12] strains of Staphylococ-
cus aureus. Fosfomycin inactivates UDP-N-acetyl-
glucosamine-3-O-enolpyruvyltransferase (MurA), an es-
sential enzyme that catalyzes the first committed step in
*Correspondence: vddonk@uiuc.edu (W.A.D.), zhao5@uiuc.edu
(H.Z.)bacterial cell wall biosynthesis [13–16], by covalent
alkylation of an active site cysteine [17, 18].
Antibiotics containing P-C bonds (phosphonates and
phosphinates) as a class are virtually uncharacterized
on the genetic and biochemical level. Although the
biosynthetic pathway for fosfomycin production in
S. wedmorensis has been proposed, heterologous pro-
duction of fosfomycin has never been achieved, sug-
gesting the possibility that additional required genes
remain to be identified [19]. The enzymes encoded by
fom1-4 are generally thought to catalyze consecutive
steps as displayed in Figure 1, where PEP is converted
to phosphonopyruvate (PnPy) by PEP mutase [20], fol-
lowed by a decarboxylation to form phosphonoacet-
aldehyde (PnAA). These first two steps are a common
theme in the biosynthesis of most phosphonates [21,
22], where the decarboxylation reaction drives the unfa-
vorable PEP mutase reaction forward [23–26]. PnAA is
known to be a biosynthetic intermediate for several
phosphonates such as bialaphos [23], fosfomycin [20],
2-aminoethylphosphonate (AEP) [27], and 2-hydroxye-
thylphosphonate (HEP) [28]. Both PEP mutase (Fom1)
and PnPy decarboxylase (Fom2) activities have been
mapped to the corresponding genes in the fosfomycin
biosynthetic pathway ofS.wedmorensis [20]. In the sub-
sequent step of the pathway, PnAA is proposed to be at-
tacked by a methyl anion derived from methylcobalamin
(MeCbl) to form 2-hydroxypropylphosphonate (HPP)
[19, 29]. This step is unusual, as it would involve
an unprecedented use of methylcobalamin. Since the
methyltransferase encoded by fom3 has not been char-
acterized in vitro due to difficulties with functional ex-
pression and purification, this proposed conversion is
still purely speculative. In the final step, HPP is oxidized
to form the epoxide [30, 31], completing the biosynthe-
sis of fosfomycin. This unusual epoxidation step cata-
lyzed by Fom4 has been characterized in detail [30,
32–38] with several different crystal structures reported
for the enzyme [37, 38]. While the mechanistic details are
still under debate, there is a consensus that this enzyme
catalyzes the conversion of HPP to fosfomycin in a ste-
reospecific manner using a mononuclear metal. Thus,
several important features of fosfomycin biosynthesis
have been discerned on the biochemical level.
On the other hand, little is known about the minimal re-
quired gene cluster for production, transcriptional con-
trol of the cluster, import/export of the antibiotic, and
the unusual methyl transfer step, thus warranting further
study. To date, heterologous production of the cluster
from S. wedmorensis has not been achieved [19], and
the vast majority of the S. fradiae fosfomycin cluster
has not been characterized or sequenced; similarly,
very little information is available about the cluster found
in Pseudomonas species, other than limited information
about the epoxidase and resistance protein [30, 39].
Therefore, we initially set out to isolate, sequence, and
characterize the fosfomycin cluster from S. fradiae
with the goal of solidifying the understanding of this bio-
synthetic pathway in terms of the open reading frames
involved.
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Pathway for Fosfomycin
PEP is converted to PnPy by Fom1 and PnPy
is converted to PnAA by Fom2. PnAA is pro-
posed to be converted to HPP by Fom3.
Fosfomycin is the product of epoxidation of
HPP by Fom4. Both HEP and AEP have
been shown to complement production of
pathways blocked at Fom2 [31].Results and Discussion
Identifying the Fosfomycin Cluster from S. fradiae
To isolate the complete fosfomycin cluster from Strep-
tomyces fradiae, a fosmid library of its genomic DNA
was prepared. S. fradiae was cultivated and its genomic
DNA was isolated in fragments of >200 kb followed by
partial Sau3A1 digestion. Cloning of 30–50 kb fragments
followed by lambda phage transduction yielded a library
of 1 3 106 fosmid-containing clones of E. coli WM4489.
A partial sequence of the methyltransferase gene (fom3)
involved in fosfomycin biosynthesis inS. fradiaewas ob-
tained by PCR using primers designed for the same
gene from S. wedmorensis (fom3 NCBI accession num-
ber: BAA32490). A small fraction of the fosmid library
(ca. 1500 clones) was screened by PCR for fom3. A total
of six fosmids were identified to contain fom3, of which
three were eliminated because the fosmid/insert-junc-
tion sequence contained an incomplete gene known to
be involved in fosfomycin biosynthesis. The remaining
three fosmids were introduced into S. lividans 66 via
conjugal transfer and integrated into the fC31 site of
the genome. The exconjugant integrants were verified
by PCR and subsequently checked under a wide variety
of conditions for fosfomycin production.
Heterologous Fosfomycin Production
A bioassay based on inhibition zones of E. coli WM5923
grown on solid penicillin assay medium 2 was devel-
oped utilizing authentic fosfomycin. This assay was ef-
fective at concentrations of authentic fosfomycin as
low as 1 mg/ml, and no inhibition zones were observed
using wild-type (WT) S. lividans 66 under any of the pro-
duction conditions tested. The three exconjugants con-
taining different fosmids referred to as 39, 40, and 45
were tested for production of fosfomycin. Exconjugants
harboring fosmids 39 and 40 never produced inhibition
zones for any of the conditions tested. However, S. livid-
ans 66 integrated with fosmid 45 (hereafter referred to as
45-S. lividans) reproducibly produced inhibition zones
when grown on ISP2 or Hickey-Tresner [40] (HT) agar
plates, with larger inhibition zones produced when
grown on the latter. Additionally, lower production of
fosfomycin was observed in liquid HT media. Previous
reports have commented on extraction of fosfomycin
from dried culture media using methanol [1]. Indeed,
the methanol extractable material from dried liquid HT
media used for 45-S. lividans growth gave reproducible
inhibition zones, while similarly prepared samples from
media used for WT-S. lividans 66 growth did not (Fig-
ure 2A). The material remaining after extraction for eitherstrain did not produce inhibition zones. 45-S. lividans
produced similar sized inhibition zones to S. fradiae
when grown under similar conditions.
Fosfomycin specifically inhibits cell wall biosynthesis
by forming a covalent adduct with C115 of UDP-N-
acetylglucosamine enolpyruvyl transferase (MurA) [13, 17],
which is responsible for the first committed step of pep-
tidoglycan biosynthesis [41]. A single mutation of MurA,
C115D, averts the formation of the covalent adduct,
while the enzyme still retains some activity [18]. To verify
that the produced antibiotic was fosfomycin, E. coli
BL21 (DE3) harboring pET20-MurA-C115D (fosfomycin
MICw20 mg/ml) was checked as a resistant strain. Nei-
ther authentic fosfomycin (100 mg/ml) nor the antibiotic
produced by 45-S. lividans (500-fold concentrated
extracted media) gave rise to inhibition zones with this
fosfomycin-specific resistant strain (Figure 2B). Thus,
the bioassay data are consistent with the heterologous
production of fosfomycin.
Biochemical and Biophysical Identification
of Fosfomycin
To further verify that 45-S. lividans was indeed produc-
ing fosfomycin, biochemical and physical identification
were sought. Unmodified murA and UDP-N-acetylenol-
pyruvoylglucosamine reductase (murB) were cloned
into overexpression vectors, overexpressed, and puri-
fied from E. coli as 63His-tagged fusions. These
enzymes were subsequently utilized in a coupled enzy-
matic assay, in which the product of MurA (UDP-N-
acetylenolpyruvoylglucosamine) is reduced by NADPH-
dependent MurB (Figure 2C), allowing convenient
monitoring of consumed NADPH at 340 nm. MurA was
incubated with MOPS buffer, fosfomycin, media extract
from WT-S. lividans 66, or 45-S. lividans and then as-
sayed in this coupled reaction. As displayed in Figure 2D,
MurA activity was lost in the 45-S. lividans sample as
well as the fosfomycin sample, while incubation with
the WT-S. lividans sample only resulted in a 2-fold
reduction in activity, likely as a result of the high salt con-
centration in the media extract. Furthermore, the cova-
lent adduct of fosfomycin with MurA was analyzed by
ESI-Q-TOF MS. MurA was incubated with buffer,
WT-S. lividans extract, 45-S. lividans extract, or authen-
tic fosfomycin in the presence of the substrate UDP-N-
acetylglucosamine, which enhances the bioactivity of
fosfomycin [15, 17, 41]. The resulting m/z values for
the desalted samples are displayed in Table S1 (see
the Supplemental Data available with this article online).
MurA incubated with authentic fosfomycin or 45-S. livid-
ans extract gave [M + 138]+ m/z and [M + 139]+ m/z
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of the molecular weight of fosfomycin (MW = 137). How-
ever, neither of these two peaks was observed for the
WT-S. lividans sample. Instead, a peak at [M + 160]+ = m/z
was observed, which was attributed to the formation
of a covalent adduct with PEP (MW = 165) present in
the concentrated media; MurA is known to form such
an adduct [41]. Thus, the MurA activity assay and
mass spectrometry data are consistent with production
of fosfomycin.
Finally, in order to directly observe the produced fos-
fomycin, 300-fold concentrated media extract was pre-
pared from 45-S. lividans. This sample was analyzed
by 31P NMR spectroscopy since phosphonates give
characteristic downfield peaks. The 31P NMR signal for
fosfomycin has been reported at 10.9 ppm [34], although
the exact chemical shift of phosphonates is highly pH
dependent. Figure 3A displays the 31P NMR spectrum
of the concentrated and extracted production media,
which shows a peak at approximately the expected
chemical shift for fosfomycin (11.9 ppm). To verify that
fosfomycin was responsible for this peak, the sample
Figure 2. Biological Detection of Fosfomycin
(A) Growth inhibition assay of E. coli WM5923 with 10 ml 100 mM fos-
fomycin, 300-fold concentrated media extract from WT-S. lividans
66, or concentrated media extract from 45-S. lividans.
(B) The fosfomycin-resistant strain BL21 pET20-MurA-C115D did
not produce inhibition zones for fosfomycin or the produced
antibiotic.
(C) MurA was assayed indirectly by coupling its reaction to that of
MurB, which can be analyzed at 340 nm due to the consumption of
NADPH.
(D) MurA enzyme activity was measured after enzyme incubation
with media extract from WT-S. lividans, 45-S. lividans, authentic
fosfomycin, or buffer alone. Less than 1% of MurA activity re-
mained for both authentic fosfomycin and the 45-S. lividans
samples.was then spiked with 1 mM authentic fosfomycin, and
the resulting spectrum (Figure 3A, inset) showed a rela-
tive increase in the peak area at 11.9 ppm, confirming
fosfomycin production. The same sample was also ana-
lyzed by high-resolution Fourier-transform mass spec-
trometry (FTMS). Figure 3B displays the combined chro-
matographic and FTMS analysis of the concentrated
and extracted production media, which shows peaks
at the correct retention time (15.2 min) and relative mo-
lecular weight value (137.0008 Da) that match those
with authentic fosfomycin, with 0.15 min and 0.96 ppm
errors, respectively. Since there are no other known em-
pirical formulas that match the exact mass within 8 ppm
and the MS/MS fragmentation matches fosfomycin
(data not shown), these data provide clear evidence
for heterologous fosfomycin production. The whole fos-
mid 45 was subsequently sequenced using primers that
annealed to a randomly inserted transposon. The final
insert sequence was 31.8 kb and was comprised of
278 overlapping sequence reads averagingw800 bp.
Analysis of the Gene Cluster
Figure 4 displays the completely sequenced insert with
putative open reading frames (Orfs). To determine which
portion of thew32 kb insert encoded genes required for
biosynthesis of fosfomycin, deletions of varying size
were made from each end of the insert to determine
the boundaries of the ability to confer antibiotic produc-
tion. We thus identified an approximately 23 kb region
that is sufficient to direct the production of fosfomycin
within S. lividans (Figure 4). This region contains 21
putative Orfs, 10 of which were previously identified in
S. wedmorensis (fomA-F, fom1-4) [19]. The central clus-
ter from Fom3 to FomC was identical in orientation to
that of S. wedmorensis, and the average predicted pro-
tein homology was 90% (Table 1).
Table 1 lists both theS. wedmorensis and next closest
homolog to Orfs fom1-4 and fomA-F from the nonredun-
dant protein database as determined by a BLAST search
[42]. Possible functions of the Orfs were assigned based
on the functions of similar proteins identified by the
BLAST searches as well as conserved domain searches.
The genes fom1 and fom2 closely resembled the homol-
ogous genes from S. wedmorensis with 98% and 95%
deduced protein homology, respectively, which have
been studied in S. wedmorensis by chemical comple-
mentation of loss of function mutations, enzymatic as-
says, and gene manipulation [19, 20]. In addition to the
PEP mutase domains, both fom1 genes have a domain
with homology to cytidylyl transferases of unknown
function. The next closest homolog to fom1 is the PEP
mutase from Bacteroides fragilis (61% homology),
a known producer of AEP [25]. The next closest homolog
to fom2 is a putative PnPy decarboxylase from Trepo-
nema denticola (63% homology). Therefore, the bioin-
formatics studies with fom1 and fom2 from S. fradiae
are consistent with the proposed function of the homol-
ogous enzymes in S. wedmorensis (Figure 1).
A BLAST search of the deduced protein sequence of
Fom3 showed that it had 95% sequence identity to
Fom3 from S. wedmorensis. These proteins have two
conserved domains. The N-terminal domain was identi-
fied as a B12-like binding domain, and the C-terminal
domain shows consensus to the radical-SAM protein
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fomycin in Production Media
(A) Culture media from 45-S. lividans was ex-
tracted with methanol, concentrated, and re-
dissolved in D2O. The
31P NMR spectrum
displays a peak with a chemical shift of
11.9 ppm. The inset displays the same sam-
ple when spiked with 1 mM fosfomycin, in
which this peak is increased in relative inten-
sity, suggesting the peak at 11.9 ppm is
fosfomycin.
(B) Overlay of chromatograms from LC/
FTMS in SRM mode from the standard (red,
bottom) and the concentrated supernatant
(black, top) and the corresponding high-
resolution mass spectra of fosfomycin from
both runs (insets at right).family that utilizes S-adenosylmethionine (SAM) to cata-
lyze reactions involving organic free radicals [43]. Similar
domain structure is found for the methyltransferases in-
volved in clorobiocin biosynthesis [44] (CloN6), biala-
phos biosynthesis (PhpK) [45], fortimycin biosynthesis
[46], and several unknown proteins proposed to be
methyltransferases. Therefore, the role of Fom3 as a
methyltransferase is likely. The deduced protein se-
quence of Fom4 from S. fradiae has 94% identity to
the epoxidase Fom4 from S. wedmorensis (Table 1). In-
terestingly, both enzymes have helix-turn-helix motifs
that are typical of DNA binding enzymes. However, the
epoxidation activity of this enzyme is unquestioned as
it has been unambiguously demonstrated [19, 31, 33,34, 47]. The next closest and the only other known
enzyme with significant homology is the epoxidase
involved in fosfomycin production in Pseudomonas
syringae [30]. Therefore, all the previously proposed bio-
synthetic enzymes in the S. wedmorensis pathway
(fom1-4) are present in S. fradiae.
FomA and FomB from S. fradiae have high homology
to the corresponding sequences from S. wedmorensis.
FomA shares homology with the amino acid kinase fam-
ily, which includes kinases that phosphorylate a variety
of amino acid substrates, as well as uridylate kinase
and carbamate kinase. The known resistance gene
fosC from Pseudomonas syringae is also homologous
to fomA [39]. FomB on the other hand has no recognized
Complete Fosfomycin Biosynthetic Pathway
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thetic Cluster
Open reading frame analysis found 28 Orfs.
Deletion analysis was performed to deter-
mine the minimal cluster. The smallest dele-
tions that no longer resulted in fosfomycin
production were D3F4 and D3E9. The largest
deletions that allowed continued fosfomycin
production were D4E3 and D3A10.conserved domains or significant homology to any other
proteins; only weak homology to ATP binding proteins
can be found. The biochemical action of both FomA
and FomB from S. wedmorensis as phosphotrans-
ferases that inactivate fosfomycin has been demon-
strated [48, 49].
Four genes (fomC-F) that have not previously been as-
signed a function were present in both theS.wedmoren-
sis and S. fradiae clusters. The genes fomE and fomF
have homology to aspartate racemase and threonyl-
tRNA synthetase, respectively, and as such are not sus-
pected to be involved in fosfomycin biosynthesis. These
two genes do have relatively high homology between
S. fradiae and S. wedmorensis. The genes fomC and
fomD, however, are found in the central cluster and ap-
pear to be transcriptionally coupled to other genes in
this cluster (Figure 4). The FomC protein sequence
from S. fradiae had much lower homology (58%) to the
fomC gene product of S. wedmorensis than other re-
spective gene products in the two clusters. However,
the first w230 amino acids have very high homology
(92%) and both sequences have conserved domainssimilar to the Fe(II)-dependent alcohol dehydrogenase
(ADH) family. The S. fradiae FomC sequence is 120
amino acids longer than that of S. wedmorensis. Curi-
ously, the previously reported S. wedmorensis FomC
[19] appears to be truncated with respect to other mem-
bers of the Fe(II)-dependent ADH family, which are
typically between 350 and 400 amino acids in length
[50–54], while FomC for S. fradiae is of the expected
size (382 amino acids). Comparisons of the DNA se-
quence shows that over the entire length of the fomC
gene from S. fradiae, 92% of the nucleotides are con-
served inS.wedmorensis, suggesting that there is a mis-
sense mutation or sequencing error in the S. wedmoren-
sis gene, resulting in the different C-terminal protein
sequences and relatively low overall homology. Several
proteins that have moderate homology (35%–25%) to
FomC have been studied in detail such as Fe2+-depen-
dent ADH from Thermotoga maritime [55] and 1,2-pro-
panediol oxidoreductase from E. coli [51]. PhpC from
the bialaphos pathway of Streptomyces viridochromo-
genes is another enzyme that shares 31% homology
[56]. Interestingly, this is the only other sequencedTable 1. Open Reading Frame Analysis of the Fosfomycin Gene Cluster
Predicted ORF
(Amino Acids)
S. wedmorensis
Homolog Identity BLAST Homolog Identity
FomC (382 aa) FomC (262 aa) 58% CAB45024 putative alcohol
dehydrogenase (Amycolatopsis orientalis, 377 aa)
35%
Fom2 (384 aa) Fom2 (384 aa) 95% NP_972020 putative phosphonopyruvate
decarboxylase (Treponema denticola, 378 aa)
63%
Fom1 (435 aa) Fom1 (435 aa) 98% BAD49328 putative phosphoenolpyruvate
phosphomutase (Bacteroides fragilis, 435 aa)
61%
FomB (330 aa) FomB (330 aa) 96% Q08381 molybdenum import ATP-binding protein
ModC (Rhodobacter capsulatus, 363 aa)
34%
FomA (266 aa) FomA(266 aa) 95% YP_562175 aspartate glutamate
uridylate kinase (Shewanella denitrificans, 279 aa)
25%
FomD (207 aa) FomD (209 aa) 91% CAC05886 hypothetical protein (Streptomyces coelicolor, 236 aa) 32%
Fom4 (198 aa) Fom4 (198 aa) 94% BAA94418 epoxidase (Pseudomonas syringae, 190 aa) 35%
Fom3 (534 aa) Fom3 (543 aa) 95% ABE54454 radical sam protein (Shewanella denitrificans, 562 aa) 29%
The closest homologs in the S. wedmonensis pathway are shown along with the next closest BLAST hit and accession code.
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The minimal gene cluster was identified
using a selectable transposon inserted in
the genes of interest. Gene clusters with dis-
ruptions of fomE, fomF, fomR, orf1, orf2,
orf3, orf5, orf6, orf8, orf10, and orf12 were
each integrated into S. lividans and checked
for bioactivity.pathway in which HEP is a known intermediate [57]. It
has been proposed in several studies that HEP and
PnAA are interconverted by a dehydrogenase (Figure 1)
[19, 29]. It is likely that FomC is the enzyme responsible
for this interconversion.
The only remaining gene without assigned function is
fomD, for which the deduced protein sequence has 91%
homology to the originally published sequence from
S. wedmorensis (NCBI accession number: BAA32492)
and 73.2% identity to a sequence reported later
(S60209). The closest homologs of fomD are both listed
as hypothetical proteins from S. coelicolor and S. aver-
mitilis with 32% and 34% homology, respectively.
Interestingly, the homologs from both related Strepto-
mycetes are located in the genome downstream of class
I and class II fumarase enzymes. Class I fumarases typ-
ically contain 4Fe4S clusters that can be oxidized under
oxidative conditions to form a 3Fe4S cluster [58, 59] in
much the same way as many members of the radical
SAM protein family [43, 60, 61]. Therefore, it can be
speculated that fomD might be related to Fom3 or
Fom4 activity, perhaps as a reductase, reactivating pro-
tein, or maturation protein, since both Fom3 and Fom4
are metalloproteins that catalyze redox chemistry.
Minimal Cluster Analysis
In addition to the previously identified genes, several
other genes in the gene cluster appeared to be impor-
tant. Deletion of the two genes (designated orf1 and
orf2) downstream of the aforementioned fom genes re-
sulted in noticeably lower production of fosfomycin,
but they were not required for fosfomycin biosynthesis
(Figure 4). Deletion of a larger DNA fragment (D3E9) re-
sulted in loss of fosfomycin production, but a smaller
deletion (D4H2) resulted in a typical level of fosfomycinproduction (Figure 4). These data strongly suggest that
FomC is required for fosfomycin production. To deter-
mine the relative importance of orf1 and orf2, disrupting
insertions into both orf1 and orf2were obtained from the
transposon sequencing protocol and were reintroduced
into S. lividans by conjugal transfer, integrated into the
chromosome, and checked by bioassay for fosfomycin
production. As displayed in Figure 5, disruption of orf2
did not affect fosfomycin production, whereas disrup-
tion of orf1 resulted in reduced fosfomycin production
similar to that observed for the orf1 and orf2 deletion.
A BLAST search was performed on these two genes,
with the results presented in Table 2. Interestingly, orf1
appears to be a DNA regulating element, which may
partially regulate fosfomycin production, whereas orf2
is not obviously involved.
Deletion analysis also revealed that an upstream frag-
ment encoding eleven additional open reading frames
was required for antimicrobial activity (Figure 4). Ten of
these Orfs (designated orf3-12) seemed to comprise a
biosynthetic cluster along with fomE-F. A BLAST search
using these genes as query sequences produced the
best hits listed in Table 2. No clear biological function
can be assigned based on homology to the fomE-F
and orf3-12 gene cluster, although these genes seem
unlikely to be involved directly in fosfomycin biosyn-
thesis. The final gene product in this upstream DNA
fragment has homology to LuxR-type helix-turn-helix
activators (Table 2) including homology (30% sequence
identity) with the activator in the bialaphos pathway
(PhpR), one of the few other completely sequenced
phosphonate antibiotic pathways [56, 62]. This gene is
therefore proposed to be an activator of the fosfomycin
cluster and is termed fomR (Figure 4). It is interesting
to note that for fomE, fomF, orf7, orf9, and orf12, no
Complete Fosfomycin Biosynthetic Pathway
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Predicted ORF
(Amino Acid) BLAST Homolog Identity
FomE (228 aa) ZP_00997194 putative aspartate racemase (Janibacter sp., 235 aa) 35%
FomF (469 aa) AAS09418 threonyl-tRNA synthetase (Lactobacillus johnsonii, 643 aa) 25%
Orf1 (308 aa) CAB45044 putative transcriptional regulator (Amycolatopsis orientalis, 335 aa) 32%
Orf2 (244 aa) ZP_00599669 putative dienelactone hydrolase (Rubrobacter xylanophilus, 220 aa) 31%
Orf3 (439 aa) AAN85500 antibiotic transport protein (Streptomyces atroolivaceus, 432 aa) 25%
Orf4 (440 aa) CAA60474 OrfE (Streptomyces hygroscopicus, 465 aa) 33%
Orf5 (366 aa) YP_288556 succinyl-diaminopimelate desuccinylase (Thermobifida fusca, 354 aa) 48%
Orf6 (333 aa) YP_236144 HMG-CoA lyase-like (Pseudomonas syringae, 342 aa) 36%
Orf7 (255 aa) AAP05735 putative coenzyme PQQ synthesis protein c (Chlamydophila caviae, 242 aa) 25%
Orf8 (312 aa) YP_012407 branched-chain amino acid aminotransferase (Desulfovibrio vulgaris, 309 aa) 35%
Orf9 (449 aa) ABB08584 hypothetical protein (Burkholderia sp., 462 aa) 22%
Orf10 (225 aa) ZP_00945807 demethylmenaquinone methyltransferase (Ralstonia solanacearum, 221 aa) 50%
Orf11 (363 aa) ZP_00800093 mandelate racemase (Alkaliphilus metalliredigenes, 363 aa) 43%
Orf12 (251aa) ZP_00863202 hypothetical protein (Bradyrhizobium sp., 244 aa) 26%
Orf13 (165 aa) CAD85407 conserved hypothetical protein (Nitrosomonas europaea, 151 aa) 42%
Orf14 (260 aa) BAB39459 bioH pimeloyl-CoA synthesis (Kurthia sp., 267 aa) 35%
Orf15 (426 aa) BAC71944 putative membrane protein (Streptomyces avermitilis, 489 aa) 31%
FomR (277 aa) BAA09943 erythropoiesis stimulating activity protein (Streptomyces thermoviolaceus, 334 aa) 32%
PhnD (322 aa) YP_481256 phosphonate-binding periplasmic protein (Frankia sp., 275 aa) 54%
PhnC (265 aa) YP_481257 phosphonate ABC transporter PhnC, ATP-binding (Frankia sp., 253 aa) 56%
PhnE (574 aa) ZP_00380826 ABC-type phosphonate permease (Brevibacterium linens, 559 aa) 48%
The NCBI accession code is given for homologous genes along with the organism and number of amino acids.homologs are found in the two completely sequenced
Streptomyces (avermertilis and coelicolor) or any other
partially sequenced Streptomycete (excluding wedmor-
ensis). At present it is unclear whether FomD is required
since no disrupting insertions were obtained. Therefore,
future studies will focus on using a different method to
knockout this gene.
To test the hypothesis that FomR is a regulator of fos-
fomycin production and to determine if any of the other
genes (orf3-12 or fomE,F) were required, gene disrupted
clones were created. Note that it was apparent from the
deletion analysis that some gene(s) were required be-
tween orf13 and orf3 (Figure 4). Disrupting insertions
into fomE, fomF, orf3, orf5, orf6, orf8, orf10, orf12, and
fomR were obtained and reintroduced into S. lividans,
and checked by bioassay for fosfomycin production.
Only gene disruption of fomR resulted in a loss of fosfo-
mycin production (Figure 5), while the remaining eight
disruptions did not. This result clearly confirms that
fomE,F and orf3, orf5, orf6, orf8, orf10, orf12 are not
essential for fosfomycin biosynthesis. Taking the
deletion analysis in account, the most straightforward
interpretation of this result is that fomR is involved in
transcriptional regulation since its deletion (Figure 4) or
disruption results in loss of fosfomycin production, it is
not part of the central cluster, and it is homologous to
DNA regulators. Although we cannot rule out that orf4,
orf7, orf9, and orf11 are essential, we believe this to be
unlikely as these genes are clustered (Figure 4, red)
with genes that are not essential according to the gene
disruption studies. Therefore, we propose that the min-
imal gene cluster is comprised of nine Orfs including
fom3 to fomC, and a required regulator, fomR (Figure 4,
yellow).
Although not required for heterologous production in
S. lividans based on deletion analysis, it is interesting
to note that genes for an ABC family transporter system
are downstream of the fom genes (Figure 4) and sharehigh homology with phosphonate uptake transporters
(phnDCE) (Table 2). These Orfs were therefore labeled
as phnD, C, and E. This transporter could be involved
in scavenging intermediates or degradation products,
or could be an exporter. If in fact these three genes con-
stitute an active phosphonate transporter, to the best of
our knowledge, it would be the first ABC family trans-
porter for phosphonates discovered in a gram-positive
bacterium.
Significance
To date, only three complete phosphonate biosyn-
thetic pathways (as demonstrated by heterologous
production) havebeenuncovered:AEP [27], bialaphos
[56], and FR900098 (A. Eliot and W.W.M., unpublished
data).We describe here the recombinant production of
fosfomycin. The gene cluster was successfully iso-
lated from S. fradiae and integrated into the chromo-
some of S. lividans 66 under the control of the natural
regulatory elements. Productionwas verified by a vari-
ety of biochemical and physical means including
31P NMR spectroscopy, high-resolution FTMS, and the
observation of an enzyme-fosfomycin covalent adduct
on the target enzyme by ESI-Q-TOF MS. Heterologous
production indicates that thew32 kb region of S. fra-
diae genomic DNA contains all of the genes required
for biosynthesis of this compound.
Since this study successfully demonstrated heterol-
ogous production of fosfomycin, it provided the op-
portunity to study the biosynthetic pathway in new
ways. Theminimal cluster was identified by gene dele-
tion analysis to be located in an w23 kb region of
S. fradiae genomic DNA containing 21 putative Orfs.
Gene disruption analysis coupled with bioinformatics
studies narrowed down the number of Orfs involved to
13 total Orfs including what we believe to be the mini-
mal gene cluster fom1-4, fomA-D, and fomR. Thus, two
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sis fomE and fomF, were found not to be required and
a proposed transcriptional activator (fomR) was dis-
covered. Interestingly, a probable ABC family phos-
phonate transporter was identified and is the first
recognized in gram-positive bacteria.
With the heterologous producer in hand, more de-
tailed genetic studies of fomC and fomDwill be carried
out to determine their role in fosfomycin biosynthesis.
Additionally, because we have shown that fom3 and
fomC can be functionally expressed in S. lividans,
future studies will focus on the heterologous over-
expression and characterization of these enzymes
using this host. Moreover, heterologous production
of fosfomycin gives knowledge of the genes required
for biosynthesis and opens the door for strain and
pathway engineering on the molecular level, which
could in the future yield high-level overproduction
strains in an amenable host such as E. coli or the pro-
duction of novel fosfomycin variants by introducing
new or mutated genes.
Experimental Procedures
Materials
Streptomyces fradiae and S. lividans 66 were obtained from the
Agricultural Research Service Culture Collection (Peoria, IL),
NRRL-3417 and NRRL-B-16148, respectively. Plasmids pJK050,
pAE4, pAE5, pAE19, pCP20 E. coli strains WM4489, WM5923, and
WM3608 were developed by the Metcalf group (A. Eliot and W.W.
Metcalf, submitted). Complete sequences of plasmids and details
of strain and plasmid construction can be obtained by request
from the authors. Fosfomycin disodium salt was obtained from
Fluka. Kanamycin, chloramphenicol, nalidixic acid, IPTG, proteinase
K, lysozyme and 2-aminoethylphosphonic acid were obtained from
Sigma-Aldrich (St. Louis, MO). ISP2, ISP4, YM, agar, beef extract,
yeast extract, malt extract, and other reagents required for cell cul-
ture were obtained from Difco (Franklin Lakes, NJ). BP clonase was
obtained from Invitrogen (Carlsbad, CA). MuA Transposase and
Phusion DNA polymerase were from Finnzymes (Espoo, Finland).
Buffer G and MaxPlax lambda particles from Epicentre (Madison,
WI). Micro biospin gel filtration columns were obtained from Bio-Rad
(Hercules, CA).
Identification of the fom3 Gene in S. fradiae
A single colony of S. fradiae grown on ISP medium 2 agar plates was
homogenized in 100 ml DMSO and 1 ml was used as template for
PCR. The PCR contained Phusion DNA polymerase and its corre-
sponding buffer and 500 nmol of the primers Fom3F1 (50-TAC GAT
CAC ATA TGA CGA TCG GTT CTC TGG-30) and Fom3R1 (50-TAC
GAT CAA AGC TTT CAG TAC TGG TTT GCG TTC C-30). These
primers were designed based on the fom3 sequence from S. wed-
morensis. The PCR product was sequenced using the same primer
set at the University of Illinois Biotechnology Center. The sequence
had high similarity to fom3 from S. wedmorensis and thus the follow-
ing screening primers were designed in regions of homology: Fom-
ScreenF (50-GGC AGC TCG GGC TTG ATC TGG-30) and Fom-
ScreenR (50-CAC GAC CTT CCG CGA TGT ACG TAC C-30). These
primers were checked for their efficiency to amplify the fom3 frag-
ment from S. wedmorensis and S. fradiae.
Construction of a Library of Genomic DNA of S. fradiae
Genomic DNA was prepared from S. fradiae grown in 700 ml glucose
yeast malt (GYM) broth [40] for 72 hr at 30C in a 2 liter baffled flask
containing approximately fifty 3 mm glass beads. The cells were har-
vested and homogenized with a sterile ground glass tissue homog-
enizer and pelleted by centrifugation (2000 3 g for 10 min), washed
with 10 ml TE25S buffer (25 mM Tris-HCl, 25 mM EDTA, 0.3 M su-
crose [pH 8]), and resuspended in 10 ml TE25S buffer, and lysozyme
was added to 2 mg/ml. After incubation at 37C for 20 min, the pro-toplasted cells were treated with 0.5 mg/ml proteinase K and incu-
bated at 50C for 30 min, and sodium dodecyl sulfate was added
to 0.5% (w/v) final concentration. After 20 min at 50C, the lysate
was washed with one volume of a 25:24:1 mixture of buffer saturated
phenol, chloroform, and isoamyl alcohol. After centrifugation at
22,500 3 g for 45 min, the aqueous layer was removed, washed
with one volume of a 24:1 mixture of chloroform and isoamyl alcohol,
and centrifuged a second time. Genomic DNA was precipitated from
the aqueous layer by addition of 0.1 vol (0.7 ml) of 5 M NaCl and
0.7 vol (5.5 ml) of isopropanol. The precipitated DNA was spooled
onto a glass rod, washed three times with 70% EtOH and once
with 100% EtOH, dried, and resuspended in 1.5 ml of TE buffer
(pH 8.0). The genomic DNA was analyzed by field inversion gel elec-
trophoresis (FIGE) and determined to be primarily DNA fragments
of >200 kb.
The prepared genomic DNA was partially digested with Sau3A1 by
performing serial dilutions of the enzyme in the DNA. The fraction
with the highest yield of w20–60 kb fragments as determined by
FIGE was then treated with shrimp alkaline phosphatase (SAP).
The fosmid vector was prepared by sequential NheI digestion,
SAP treatment, and BamHI digestion. The SAP-treated genomic
DNA fraction was ligated with prepared pJK050 overnight at 16C,
followed by ethanol precipitation and packaging into lambda phage
using the MaxPlax packaging extract according to the manufac-
turer’s instructions. E. coli WM4489 cells were transfected with the
packaged library and plated on LB + 12 mg/ml chloramphenicol
(Cm) agar plates. WM4489 is an E. coli DH10B derivative that con-
tains the trfA33 gene under the control of a rhamnose-inducible
promoter. Individual colonies (w1500) were picked into standard
96-well plates with each well containing a single 3 mm glass bead
(to aid mixing) and 200 ml LB + 12 mg/ml Cm and grown overnight
with shaking at 37C.
Library Screening
Cell culture (10 ml) from 48 clones was pooled, boiled in water
(100 ml), and used as a template for PCR reactions containing
500 nmol of primers FomScreenF and FomScreenR and Taq DNA
polymerase in 13 PCR premix G, with the annealing temperature
of 55C, extension at 72C for 40 s, and melting temperature at
95C—30 cycles in total. Subsequent row and column pooling al-
lowed positive clones to be identified. Fosmid DNA was isolated
from single positive clones grown overnight in 5 ml LB + 12 mg/ml
Cm + 0.2% rhamnose using a Qiagen Miniprep kit. In order to add
the functions necessary for transfer and integration into the genomic
DNA of S. lividans, the purified fosmids were individually recom-
bined in vitro with similarly purified pAE4 using a BP clonase kit
according to the manufacturer’s instructions. The reaction mixtures
were used to transform E. coli WM3608 [56], and successfully
recombined plasmids were selected on LB + 12 mg/ml Cm + 50
mg/ml apramycin (Apr) agar plates. These transformants were
then used as donors for conjugal transfer of the fosmids to S. livid-
ans 66 following the ‘‘high-throughput’’ protocol described previ-
ously with the exception that the entire E. coli/S. lividans mixture
was spotted on R2 no-sucrose media in 2.5 ml aliquots [63]. After
16–20 hr at 30C, plates were flooded with 2 ml of a mixture of
1 mg/ml each nalidixic acid (Nal) and Apr and incubated at 30C
for an additional 5–7 days, at which point S. lividans exconjugants
were picked and restreaked on ISP2 + 50 mg/ml Nal + 30 mg/ml
Apr + 12 mg/ml Cm and allowed to grow for several days, at which
time integration was confirmed by PCR using the screening primers
for Fom3.
Fosmid Junction Sequencing
Each of the fosmid constructs that yielded positive PCR products for
fom3were sequenced from their junction points with the fosmid vec-
tor pJK050 using primers that anneal to the T7 promoter on one side
of the vector or T3 promoter on the other side of the vector. The se-
quences were analyzed using BLASTX for any open reading frames
that might help identify a fosmid that did not contain the complete
cluster.
Production of Fosfomycin by S. lividans
Each of the S. lividans exconjugants was plated on HT agar plates
[40] or inoculated into HT liquid media and incubated at 30C.
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the case of liquid media, samples were concentrated to dryness un-
der vacuum and extracted with methanol several times. The metha-
nol extract was filtered and dried under vacuum resulting in a fine
powder that was dissolved in water to effectively concentrate the
samples between 10- and 500-fold. Several other production media
in solid and liquid form were tested including HT + phosphate, ISP2,
ISP2 + phosphate, S media, ISP4, and mannitol soy media [40]. Of
these, only ISP2 also allowed production of fosfomycin, however,
at a significantly lower level.
Bioauthentication
E. coli WM5923 has the three component E. coli phosphonate trans-
porter phnCDE integrated into the chromosome under an IPTG in-
ducible promoter resulting in a MIC value of w1 mg/ml fosfomycin
in the presence of IPTG (W.W.M., unpublished data). E. coli BL21
pET20-MurA C115D has a MIC value >20 mg/ml for fosfomycin in
the presence of IPTG, due to MurA C115D being catalytically compe-
tent but unable to form a covalent adduct with fosfomycin [18]. An
overnight culture of either WM5923 or BL21 pET20-murA C115D
was diluted 10-fold in water, and 100 ml was spread on the surface
of a Penicillin Assay Medium 2 plate with 25 ml 0.5 M IPTG. The plate
was allowed to dry and then plugs of solid production medium or fil-
ter discs saturated with methanol extracted liquid medium from the
S. lividans exconjugants were placed on the surface. After overnight
incubation at 30C, the plates were analyzed for inhibition zones.
Cloning and Purification of E. coli MurA and MurB
TheE. coli murA gene was amplified fromE. coliBL21 (DE3) genomic
DNA using PCR with NdeI-MurA-forward (50-CGA CAG TCC ATA
TGG ATA AAT TTC GTG TTC-30) and XhoI-MurA-reverse (50-ATT
TCA ATC TCG AGT TCG CCT TTC ACA CGC TC-30) primers, and
the resulting PCR product was digested with NdeI and XhoI and li-
gated with similarly prepared pET20b. ThemurB gene was amplified
using HindIII-MurB-forward (50-GAC GAT CGA AGC TTG CAT GAA
CCA CTC CTT AAA ACC-30) and XhoI-MurB-reverse (50-CAG CAT
GAC TCG AGT GAA ATT GTC TCC ACT GC-30) primers, digested
with HindIII and XhoI, and ligated into similarly prepared pET28a.
These two constructs were sequenced at the University of Illinois
Biotechnology Center and utilized to transform BL21 (DE3).
A murA mutant C115A was created using a QuikChange Site-
Directed Mutagenesis Kit (Stratagene, La Jolla, CA) following the
manufacturer’s instructions.
Expression of either murA or murB gene was induced by addition
of IPTG to a final concentration of 0.2 mM in a 1 liter culture grown in
LB broth + 50 mg/ml kanamycin (Km) at 37C to an OD600 of 0.6. The
culture was incubated at 20C for an additional 16 hr, at which point
the cells were harvested and lysed by addition of lysozyme, a freeze-
thaw cycle, and sonication. The lysate was cleared by centrifuga-
tion, and the enzyme was purified by metal affinity chromatography
using Ni-NTA agarose according to the manufacturer’s instructions.
The purified enzymes were concentrated and stored in 20 mM
HEPES, 15% glycerol, 500 mM NaCl (pH 7.5) at a concentration of
30 mg/ml for MurA and 10 mg/ml for MurB. MurA was desalted
directly before use by gel filtration using micro biospin columns.
Enzyme Assay for Fosfomycin Detection
Activity of MurA was measured indirectly utilizing MurB, by observ-
ing the decrease of absorbance at 340 nm resulting from oxidation of
NADPH during the reaction (Figure 2A). All substrate and enzyme so-
lutions were prepared in 50 mM MOPS (pH 7.5). An assay mix con-
taining MurB (100 mg/ml), NADPH (100 mM), and PEP (150 mM) was
prepared. An enzyme solution was prepared containing MurA
(70 mg/ml) and UDP-N-acetylglucosamine (3.5 mM). The enzyme so-
lution (15 ml) was incubated with various concentrations of authentic
fosfomycin (15 ml), or 100-fold concentrated media extract from ei-
ther suspected fosfomycin-producing S. lividans exconjugants or
WT-S. lividans 66. After 10 min incubation at 25C, the 30 ml MurA
mixture was added to 500 ml of the assay mix and the decrease in ab-
sorbance at 340 nm was monitored by Varian CARY Bio-100 UV-Vis
spectrophotometry (Palo Alto, CA). The background rate of NADPH
oxidation was recorded without addition of MurA and substracted
from all readings. Multiple readings were averaged and normalized
to the addition of uninhibited MurA enzyme mixed only with buffer.31P NMR Detection of Fosfomycin
HT culture supernatant was extracted as described above and the
extracted material was redissolved in D2O to an effective concentra-
tion of 300-fold. 31P NMR spectra were recorded on a Varian Unity
500 spectrometer with a 5 mm QUAD probe (Nalorac Cryogenics,
Martinez, CA) in the Nuclear Magnetic Resonance Laboratory at
the University of Illinois at Urbana-Champaign. Spectra were exter-
nally referenced to an 85% phosphoric acid standard set at 0 ppm. A
total of 10,000 acquisitions were averaged and in order to verify that
the observed peak was fosfomycin, 1 mM fosfomycin was added to
the sample and an additional 100 acquisitions were averaged.
Fourier-Transform Mass Spectrometric Detection
of Fosfomycin
Authentic fosfomycin was diluted with 1:1 methanol/water and in-
fused into a 7 Tesla LTQ-FT mass spectrometer (Thermo Finnigan,
San Jose, CA) at a flow rate of 3 ml/min in negative ion mode. The in-
strument was tuned to acquire high-resolution FTMS data of intact
ions and lower-resolution ion trap data for MS/MS fragmentation.
The standard was then diluted 10-fold in acetonitrile for on-line
LC/MS using hydrophilic interaction chromatography (PolyLC,
Columbia, MD) in negative ion mode with three repeating events:
an intact low-resolution ion trap scan, an intact high-resolution FT
scan, and a selected reaction monitoring (SRM) scan using three
breakdown product ions of fosfomycin at m/z 63, 79, and 81. Fosfo-
mycin eluted at 15 min during a gradient of 5% 100 mM ammonium
acetate (pH 4)/95% acetonitrile to 80% 100 mM ammonium acetate
(pH 4)/20% acetonitrile over 20 min. The same LC/MS run was used
for the concentrated culture supernatant (10 ml), first diluted 10-fold
with water before being diluted 10-fold again with acetonitrile/
methanol (9:1).
Mass Spectrometric Detection of MurA-Fosfomycin Adduct
Samples of 100-fold concentrated media extract prepared as de-
scribed above for 45-S. lividans and WT-S. lividans were incubated
with 100 mM MurA in the presence of 1 mM UDP-N-acetylglucos-
amine, respectively. After 1 hr at 25C, small molecules were
removed from the samples by gel filtration on micro biospin col-
umns. Samples were submitted to the University of Illinois Mass
Spectrometry Laboratory where they were desalted by C-4 zip-tip
and analyzed by ESI-Q-TOF in positive ion mode with 0.1% formic
acid.
Sequencing of Fosmid 45
A library of transposon insertions was generated in an in vitro reac-
tion of the gel purified BglII-fragment of pAE5 that contained a Km
selectable transposon, the pAE4-retrofitted fosmid 45, and MuA
transposase according to the manufacturer’s instructions. E. coli
WM4489 was transformed with the reaction products, and success-
ful insertions were selected on LB + 25 mg/ml Km. Colonies were
picked into library plates containing 1.5 ml LB + 25 mg/ml Apr + 25
mg/ml Km + 0.2% rhamnose and grown overnight with shaking at
37C. Fosmid purification and sequencing was carried out on 192
clones at the University of Illinois Biotechnology Center using TnFor
(50-CTT TCT AGA GAA TAG GAA CTT CGG G-30) and TnRev (50-GAC
GAG TTC TTC TGA GCG G-30) primers that anneal within the trans-
poson. The resulting 384 sequence reads were assembled into con-
tiguous fragments using Sequencher (Gene Codes Corp., Ann Ar-
bor, MI). Remaining gaps were filled in by obtaining further
sequence using specifically designed primers. Potential open read-
ing frames were identified using BLAST analysis (http://www.ncbi.
nlm.nih.gov) and visual inspection.
Deletion and Gene Disruption Analysis
To determine the boundaries of the fosfomycin cluster, various
deletions were made by recombination between either the FRT or
loxP site of the fosmid backbone and the matching site on the trans-
poson. In each case, cells ofE. coliWM4489 containing a transposon
insertion product (selected with 25 mg/ml Km and 12 mg/ml Cm) were
made electrocompetent and transformed with either pCP20 (ex-
pressing FLP recombinase under control of a temperature sensitive
promoter) [64] or pAE19 (expressing Cre recombinase under control
of the same promoter). Transformants were selected on LB + 100
mg/ml ampicillin (Amp) at 30C, and subsequent single colonies
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grown at 42C. The resulting colonies were again restreaked on
LB + 12 mg/ml Cm + 30 mg/ml Apr plates, as well as LB + 50 mg/ml
Km and LB + 100 mg/ml Amp plates and grown at 37C to check
for sensitivity. Correctly deleted clones did not grow on Km or
Amp, indicating the Km marker had been deleted and the clone
was cured of the recombinase encoding plasmid. For gene disrup-
tion experiments, the disruptions consisted of the randomly inserted
Km selectable transposon utilized for sequencing. Fosmid contain-
ing clones of E. coli WM4489 with the transposon disrupting the de-
sired gene were chosen with attention to location and polarity based
on the sequencing reads obtained for each clone. For both disrup-
tion and deletion analysis, fosmid DNA was isolated from these
strains, checked for correct deletion or disruption by BamHI restric-
tion analysis, and integrated into S. lividans 66 using the previously
described protocol. Exconjugants were assayed for the ability to
produce fosfomycin on HT agar plates by the aforementioned bioas-
say with WM5923 as the indicating strain.
Supplemental Data
Supplemental Data include one table and are available at http://
www.chembiol.com/cgi/content/full/13/11/1171/DC1/.
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